Eugene P. Kennedy
2020
In 2020, Eugene P. Kennedy earned a total compensation of $1.1M as Chief Medical Officer at NewLink Genetics, a 25% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $300,770 |
|---|---|
| Option Awards | $253,021 |
| Salary | $459,638 |
| Stock Awards | $70,830 |
| Other | $62,040 |
| Total | $1,146,299 |
Kennedy received $459.6K in salary, accounting for 40% of the total pay in 2020.
Kennedy also received $300.8K in non-equity incentive plan, $253K in option awards, $70.8K in stock awards and $62K in other compensation.
Rankings
In 2020, Eugene P. Kennedy's compensation ranked 8,043rd out of 13,090 executives tracked by ExecPay. In other words, Kennedy earned more than 38.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,043 out of 13,090 | 39th |
Division Manufacturing | 3,411 out of 5,621 | 39th |
Major group Chemicals And Allied Products | 1,379 out of 2,254 | 39th |
Industry group Drugs | 1,200 out of 1,954 | 39th |
Industry Pharmaceutical Preparations | 893 out of 1,459 | 39th |
Source: SEC filing on April 6, 2021.
Kennedy's colleagues
We found five more compensation records of executives who worked with Eugene P. Kennedy at NewLink Genetics in 2020.
News
NewLink Genetics CEO Richard Hawkins' 2020 pay jumps 200% to $2.2M
April 6, 2021
NewLink Genetics Former Chief Executive & Scientific Officer Charles Link's 2019 pay falls 38% to $1.7M
June 23, 2020
NewLink Genetics Chief Executive & Scientific Officer Charles Link's 2018 pay slips 18% to $2.8M
April 5, 2019